Frontlight ResearchEarly access
Trial site
Robert Wood Johnson Medical School
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes2 trials
- Barrett's oesophagus1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Familial hypercholesterolaemia1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Parkinson disease1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Rheumatoid arthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Endogenex, Inc.2 trials
- Novartis Pharmaceuticals2 trials
- Rutgers, The State University of New Jersey2 trials
- argenx1 trial
- Bial R&D Investments, S.A.1 trial
- and 3 more
Running trials
Enrolling by invitation
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Barrett's oesophagus1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026